Can we map a Tumor's genes fast enough to help patients?
NCT ID NCT03546127
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This pilot study tested whether advanced genetic sequencing of tumors can be done quickly enough to guide treatment decisions. Researchers took blood and tumor samples from 24 adults with advanced soft-tissue sarcoma or metastatic colorectal cancer. They measured how long it took to get a complete genetic report back to the doctor. The goal was to see if this process is practical in a real-world hospital setting.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Next Generation Sequencing (genetic testing of tumor and blood samples)
What this could lead to
If successful, this could show that routine genetic profiling of tumors is feasible within a useful timeframe, potentially helping doctors choose more personalized treatments for cancer patients.
What could go wrong
This is a very small pilot study (24 patients) focused only on feasibility and timing, not on whether profiling actually improves patient outcomes. It may not lead to direct treatment benefits.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CEA / Centre National de Recherche en Génomique Humaine
Évry, 91057, France
-
Hôpital Européen Georges Pompidou
Paris, 75000, France
-
Institut Bergonié
Bordeaux, 33076, France